Christina Dent talks about founding End It For Good, her journey to rethinking drugs and addiction and how Mississippi can ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...

NSC51349 selectively inhibits cutaneous HPV replication by targeting viral E2 activity, potentially paving the way for first ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

Two Moundsville men were arrested after a July 4 traffic stop in Monroe County led to the discovery of methamphetamine and ...

Landmark research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some promising cancer treatments are causing serious side effects, and offers ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...